| Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis E De Azambuja, M Brandão, H Wildiers, A Laenen, S Aspeslagh, ... ESMO open 5 (5), e000947, 2020 | 74 | 2020 |
| Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer K Van Baelen, T Geukens, M Maetens, V Tjan-Heijnen, CJ Lord, S Linn, ... Annals of Oncology 33 (8), 769-785, 2022 | 47 | 2022 |
| A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling P Altea-Manzano, G Doglioni, Y Liu, AM Cuadros, E Nolan, ... Nature cancer 4 (3), 344-364, 2023 | 34 | 2023 |
| Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial L Liesenborghs, I Spriet, D Jochmans, A Belmans, I Gyselinck, ... EBioMedicine 66, 2021 | 26 | 2021 |
| Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients A Bohlok, P Vermeulen, S Leduc, E Latacz, L Botzenhart, F Richard, ... NPJ Breast Cancer 6 (1), 64, 2020 | 19 | 2020 |
| A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of … T Devos, T Geukens, A Schauwvlieghe, KK Ariën, C Barbezange, ... Trials 21, 1-15, 2020 | 17 | 2020 |
| Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer T Geukens, M De Schepper, F Richard, M Maetens, K Van Baelen, ... European Journal of Cancer 188, 152-160, 2023 | 16 | 2023 |
| Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis. ESMO Open 2020; 5 E De Azambuja, M Brandão, H Wildiers, A Laenen, S Aspeslagh, ... | 9 | |
| Obesity-associated changes in molecular biology of primary breast cancer HL Nguyen, T Geukens, M Maetens, S Aparicio, A Bassez, A Borg, ... Nature communications 14 (1), 4418, 2023 | 8 | 2023 |
| Belgian Collaborative Group on COVID-19 Hospital Surveillance and the Belgian Society of Medical Oncology (BSMO) E de Azambuja, M Brandão, H Wildiers, A Laenen, S Aspeslagh, ... Impact of Solid Cancer on In-Hospital Mortality Overall and among Different …, 2020 | 7 | 2020 |
| Digital analysis of distant and cancer-associated mammary adipocytes E Isnaldi, F Richard, M De Schepper, D Vincent, S Leduc, M Maetens, ... The Breast 54, 179-186, 2020 | 4 | 2020 |
| Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer K Van Baelen, HL Nguyen, AS Hamy-Petit, F Richard, MM Karsten, ... European Journal of Cancer 191, 112988, 2023 | 3 | 2023 |
| Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential … F Richard, M De Schepper, M Maetens, S Leduc, E Isnaldi, T Geukens, ... The Breast 69, 476-480, 2023 | 3 | 2023 |
| Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future T Geukens, M Brandão, A Laenen, J Collignon, C Van Marcke, I Louviaux, ... ESMO open 7 (6), 100610, 2022 | 3 | 2022 |
| Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding C Riera-Domingo, E Leite-Gomes, I Charatsidou, P Zhao, G Carrá, ... Science Advances 9 (12), eadd5028, 2023 | 2 | 2023 |
| Inter-lesion heterogeneity of HER2-status in metastatic breast cancer: possible implications for treatment with anti-HER2 antibody-drug conjugates T Geukens, M De Schepper, F Richard, M Maetens, K Van Baelen, ... CANCER RESEARCH 83 (5), 2023 | 2 | 2023 |
| Abstract HER2-16: HER2-16 Inter-lesion heterogeneity of HER2-status in metastatic breast cancer: possible implications for treatment with anti-HER2 antibody-drug conjugates T Geukens, M De Schepper, F Richard, M Maetens, K Van Baelen, ... Cancer Research 83 (5_Supplement), HER2-16-HER2-16, 2023 | 2 | 2023 |
| The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive … E Isnaldi, F Richard, M De Schepper, S Leduc, M Maetens, T Geukens, ... NPJ breast cancer 8 (1), 90, 2022 | 2 | 2022 |
| Research autopsy programmes in oncology: shared experience from 14 centres across the world T Geukens, M Maetens, JE Hooper, S Oesterreich, AV Lee, L Miller, ... The Journal of Pathology, 2024 | 1 | 2024 |
| Abstract P6-14-06: Histopathological and immune characterization of liver metastases from patients with breast cancer S Leduc, M De Schepper, P Vermeulen, G Floris, E Biganzoli, V Donckier, ... Cancer Research 83 (5_Supplement), P6-14-06-P6-14-06, 2023 | 1 | 2023 |
